Back to top
more

High Tide (HITI)

(Delayed Data from NSDQ)

$2.39 USD

2.39
453,298

+0.09 (3.91%)

Updated May 15, 2024 04:00 PM ET

After-Market: $2.40 +0.01 (0.42%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Henry Schein (HSIC) Extends Partnership With Special Olympics

by Zacks Equity Research

Henry Schein's (HSIC) extended collaboration with Special Olympics is likely to promote wellness and health education for athletes with ID around the world.

Here's Why You Should Retain Zimmer Biomet (ZBH) Stock for Now

by Zacks Equity Research

Strong procedure recovery and progress on the four-pillar strategy bode well for Zimmer Biomet (ZBH).

Ayr Wellness Inc. (AYRWF) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Ayr Wellness Inc. (AYRWF) delivered earnings and revenue surprises of -58.82% and 2.24%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts

by Zacks Equity Research

Within Neuromodulation, Boston Scientific's pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.

QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus

by Zacks Equity Research

QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.

Why High Tide Inc. (HITI) Dipped More Than Broader Market Today

by Zacks Equity Research

High Tide Inc. (HITI) reachead $2.24 at the closing of the latest trading day, reflecting a -1.32% change compared to its last close.

Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Capricor (CAPR) delivered earnings and revenue surprises of -181.82% and 50.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Teleflex (TFX) Expands Vascular Access Portfolio With New Launch

by Zacks Equity Research

Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.

Is High Tide (HITI) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how High Tide Inc. (HITI) and Hologic (HOLX) have performed compared to their sector so far this year.

High Tide Inc. (HITI) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

The latest trading day saw High Tide Inc. (HITI) settling at $2.16, representing a -1.37% change from its previous close.

Riya Anand headshot

How You Should Play Hologic (HOLX) Ahead of Q2 Earnings

by Riya Anand

Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.

Moumi Mondal headshot

Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings?

by Moumi Mondal

Lifeward's (LFWD) first-quarter 2024 results are expected to reflect the benefits of several milestone achievements from last year.

High Tide Inc. (HITI) Advances While Market Declines: Some Information for Investors

by Zacks Equity Research

High Tide Inc. (HITI) closed at $2.03 in the latest trading session, marking a +0.5% move from the prior day.

Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth

by Zacks Equity Research

Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.

The Zacks Analyst Blog Highlights Comfort Systems, High Tide, CuriosityStream and Turtle Beach

by Zacks Equity Research

Comfort Systems, High Tide, CuriosityStream and Turtle Beach are included in this Analyst Blog.

High Tide Inc. (HITI) Declines More Than Market: Some Information for Investors

by Zacks Equity Research

In the closing of the recent trading day, High Tide Inc. (HITI) stood at $2.21, denoting a -1.34% change from the preceding trading day.

Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?

by Zacks Equity Research

The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.

High Tide (HITI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

by Zacks Equity Research

High Tide (HITI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Tirthankar Chakraborty headshot

US Economy is Booming in 2024: Here's How to Trade It

by Tirthankar Chakraborty

With the U.S. economy on a hot streak, it makes sense to invest in growth stocks such as Comfort Systems USA (FIX), High Tide (HITI), CuriosityStream (CURI) and Turtle Beach (HEAR).

Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?

by Zacks Equity Research

The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.

Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.

Benjamin Rains headshot

How to Find Cheap Stocks Under $10 to Buy Now

by Benjamin Rains

Along with the cheap price tags, the stocks we learn how to search for earn strong Zacks Ranks, driven by improving earnings outlooks. On top of that, Wall Street is high on all of these stocks.

Align Technology (ALGN) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Align Technology's (ALGN) first-quarter 2024 performance is likely to reflect the strength of the Clear Aligner and Systems & Services businesses.

What's in Store for Boston Scientific (BSX) in Q1 Earnings?

by Zacks Equity Research

Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.

What's in Store for Thermo Fisher (TMO) in Q1 Earnings?

by Zacks Equity Research

Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.